杜比卢马布可以减少双胞胎的,这些双胞胎患有Sjögren-Larsson综合征
Kennedy Gallagher1, Rame Yousif1, Kathryn Hummel1
1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Pediatric dermatology
|October 5, 2025
概括
斯约格伦-拉森综合征 (SLS) 是一种罕见的遗传疾病,导致严重的. 杜皮卢马布治疗显著减少了,改善了SLS的双胞胎女孩的睡眠和生活质量.
科学领域:
- 遗传学 遗传学 是一个
- 皮肤病学 皮肤病学
- 神经学 神经学
背景情况:
- 斯约格伦-拉森综合征 (SLS),也称为ALDH3A2-综合征表皮分化障碍 (sEDD),是一种罕见的遗传疾病.
- 关键特征包括皮肤加厚,性,智力障碍和难以治疗的.
- 目前用于SLS相关的的治疗方法通常是无效的,这突显了未满足的医疗需求.
研究的目的:
- 评估dupilumab在治疗Sjögren-Larsson综合征患者难治性的疗效.
- 评估dupilumab对SLS患者睡眠和生活质量的影响.
主要方法:
- 两名4岁双胞胎女孩的案例研究,有遗传确认的SLS.
- 用dupilumab进行治疗,dupilumab是一种向介素-4受体信号传递的生物药物.
- 在6个月内评估的严重程度得分,睡眠质量和不良影响.
主要成果:
- 杜皮卢马布治疗导致的严重程度显著而持久地改善.
- 在6个月内观察到的评分显著下降.
- 报告说,睡眠和整体生活质量得到改善,没有任何不良影响.
结论:
- 杜皮卢马布在缓解与Sjögren-Larsson综合征相关的衰弱性方面表现出有希望的疗效.
- 这些发现支持进一步临床研究dupilumab作为SLS相关的的治疗选择.
- 准介素-4受体信号传递可能是治疗罕见遗传性皮肤疾病中严重的可行策略.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
631
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
631
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
488
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
488
Nephrotic Syndrome II : Assessment and Medical Management
200
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
200


